Cell energy latest in anti-aging battle

By Katie Bird

- Last updated on GMT

A skin care range has been formulated to help regenerate healthy
skin based on a technology that regulates the body's cellular
energy systems.

Nurigene skin care line is part of the money making arm of a US biotech company that uses the same technology to develop drugs against neurodegenerative diseases such as Parkinson's and Huntington's disease. According to the company the product line has been clinically proven to increase cell turnover, improve skin firmness and elasticity, and improve the skin's ability to retain moisture. Cellular energy system​ Avicena, the company behind the technology, focus on the body's creatine kinase and creatine transporter systems. Creatine is a compound occurring in muscle, brain, heart, retina and skin tissue cells. In these cells the creatine is transported from the cytoplasm into the mitochondria, where a phosphate group is added to the molecule. The compound is stored in this form until energy is needed. At this point the phosphate group is given to an adenosine diphosphate molecule resulting in adenoisine tripohosphate - the body's basic energy molecule. Avicena has been concentrating on regulating this energy system, as a lack of cellular energy causes certain cells to degenerate at a more rapid rate, linked to the onset of certain neurodegenerative diseases like Parkinson's. Cellular energy and the skin ​ Avicena claim that the skin also benefits from regulating the cell's energy system, and they have patented the core technology in Nurigene as Advanced Skin Nourishment. The range promotes optimal cellular regeneration by providing critical nourishment to the skin cell's as they are growing, according to the company. Clinical trials were carried out that according to the company, demonstrate that Nurigene leads to significant improvements in skin cell turnover, skin firmness, skin elasticity and the skin's ability to retain moisture. Avicena currently has a range of dermaceutical ingredients and formulations on the market, which it sells to dermaceutical and cosmoceutical firms. This, along with the Nurigene range, allows the company to exploit the large skin care market in the US and the financial benefits that this may hold. "By applying our proprietary technology platform to the development of next-generation dermaceuticals, we are able to tap into the growing $9 billion U.S. skin care market",​ Belinda Tsao Nivaggioli, Avicena's CEO stated.

Related topics: Formulation & Science, Skin Care

Related news

Show more

Related products

show more

Powders to packaging: cosmetic quality control

Powders to packaging: cosmetic quality control

Stable Micro Systems | 20-Nov-2017 | Technical / White Paper

Physical analysis is vital at every step of development for cosmetic products, from perfecting the consistency of creams, to ensuring gels glide on – and...

The best multi-tasking cosmetic ingredient

The best multi-tasking cosmetic ingredient

Sabinsa: Innovating the Science of Cosmetics® | 20-Nov-2017 | Product Brochure

The antioxidant benefits of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae), commonly known in India as amla (Indian gooseberry), are...

SymDiol® 68 a smart synergistic protectant

SymDiol® 68 a smart synergistic protectant

Symrise | 08-Nov-2017 | Product Brochure

Today, cosmetic formulators face an increasingly challenging task to protect formulations and at the same time answering consumers’ desires for less preservatives...

Related suppliers